Cripps N P, Ward A S
Royal Naval Hospital, Haslar.
J R Nav Med Serv. 1994 Summer;80(2):66-70.
Details are reported of four patients who developed serious distant haemorrhagic complications while undergoing peripheral arterial thrombolysis with intra-arterial tissue plasminogen activator (t-PA). The thrombolytic regime comprised a 20 mg bolus of t-PA followed by a continuous infusion of 1 mg/hr. Four additional cases of haemorrhage at the catheter entry site were also encountered in a group of 23 patients exposed to the bolus-infusion t-PA regimen. The high haemorrhage rate (31%) is a significant disadvantage of this thrombolytic protocol.
报告了4例患者在接受动脉内组织型纤溶酶原激活剂(t-PA)进行外周动脉溶栓时发生严重的远处出血并发症的详细情况。溶栓方案包括静脉推注20mg t-PA,随后以1mg/小时的速度持续输注。在一组接受推注-输注t-PA方案的23例患者中,还遇到了另外4例导管穿刺部位出血的情况。高出血率(31%)是该溶栓方案的一个显著缺点。